These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18282630)

  • 1. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.
    Hadaegh F; Ghasemi A; Padyab M; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2008 May; 80(2):328-34. PubMed ID: 18282630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius.
    Cameron AJ; Zimmet PZ; Soderberg S; Alberti KG; Sicree R; Tuomilehto J; Chitson P; Shaw JE
    Diabet Med; 2007 Dec; 24(12):1460-9. PubMed ID: 17976203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.
    Cheung BM; Wat NM; Man YB; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Diabetes Care; 2007 Jun; 30(6):1430-6. PubMed ID: 17337491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
    Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
    Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
    Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
    J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.